Paid Clinical Trials Tallahassee

Discover 98 paid clinical trials in Tallahassee, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 98

Sacituzumab Tirutecan & PembrolizumabA Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Thomasville GA, Gainesville FL, Altamonte Springs FL, Orlando FLshow 26 more

Code:

NCT06312176

Conditions

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab tirumotecan

Pembrolizumab

Paclitaxel

Nab-paclitaxel

Capecitabine

Immunotherapy TreatmentsStudy With Various Immunotherapy Treatments in Participants With Lung Cancer

Recruiting

PHASE2

Sponsor:

Gilead Sciences

Location:

Tallahassee FL, The Villages FL, Sarasota FL, Birmingham ALshow 10 more

Code:

NCT05676931

Conditions

Advanced Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Domvanalimab

Quemliclustat

Zimberelimab

Docetaxel

Platinum-Based Doublet

Observational StudyDysarthria Management for Minor Groups

Recruiting

Sponsor:

Florida State University

Location:

Tallahassee FL

Code:

NCT06593860

Conditions

Parkinson Disease

Dysarthria

Eligibility Criteria

Sex: All

Age: 25 - 70+

Healthy Volunteers: Not accepted

Interventions

Remote speech rehabilitation

SelfWrapSAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

Recruiting

Sponsor:

VenoStent

Location:

Tallahassee FL, Orangeburg SC, Charleston SC, Greenville SCshow 17 more

Code:

NCT06001827

Conditions

Chronic Kidney Diseases

End Stage Renal Disease

Arteriovenous Fistula

Hemodialysis Access Failure

ESRD

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SelfWrap Bioabsorbable Perivascular Wrap

Untreated AVF Control

Fianlimab & CemiplimabA Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Recruiting

PHASE2

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Tallahassee FL, Clermont FL, Orange City FL, Saint Petersburg FLshow 18 more

Code:

NCT05785767

Conditions

Advanced Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

fianlimab

cemiplimab

Placebo

Exercise TrainingExercise Training and Fat Metabolism in Postmenopausal Women

Recruiting

Sponsor:

Florida State University

Location:

Tallahassee FL

Code:

NCT05351476

Conditions

Postmenopausal Symptoms

Obesity

Prediabetic State

Eligibility Criteria

Sex: Female

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Resistance Exercise

Endurance Exercise

Tendyne TranscatheterClinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Recruiting

Sponsor:

Abbott Medical Devices

Location:

Tallahassee FL, Gainesville FL, Clearwater FL, Bradenton FLshow 64 more

Code:

NCT03433274

Conditions

Mitral Regurgitation

Mitral Insufficiency

Mitral Valve Insufficiency

Cardiovascular Diseases

Valve Disease, Heart

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tendyne Mitral Valve System

MitraClip System

MILDMILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Centerville FL, Douglas GA, Gainesville FL, Alma GAshow 1096 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

CamizestrantAn Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Tallahassee FL, Thomasville GA, Dothan AL, Gainesville FLshow 143 more

Code:

NCT05952557

Conditions

Breast Cancer, Early Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Camizestrant

Tamoxifen

Anastrozole

Letrozole

Exemestane

Selinexor, Pomalidomide, Dexamethasone, ElotuzumabA Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

Recruiting

PHASE3

Sponsor:

Stichting European Myeloma Network

Location:

Tallahassee FL, Saint Petersburg FL, Fort Myers FL, Charleston SCshow 26 more

Code:

NCT05028348

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Elotuzumab

Pomalidomide

Dexamethasone Oral